Enoxaparin but not unfractionated heparin causes a dose-dependent increase in plasma TGF- 1 during haemodialysis: a cross-over study | Zendy

Beata Naumnik | Zendy; Jacek Borawski | Zendy; Krystyna Pawlak | Zendy; Małgorzata Myśliwiec | Zendy

Open Access

Enoxaparin but not unfractionated heparin causes a dose-dependent increase in plasma TGF- 1 during haemodialysis: a cross-over study

Author(s) -

Beata Naumnik,

Jacek Borawski,

Krystyna Pawlak,

Małgorzata Myśliwiec

Publication year - 2007

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfm082

Subject(s) - medicine , heparin , hemodialysis , bolus (digestion) , dialysis , platelet , platelet factor 4 , growth factor , endocrinology , urology , receptor

Transforming growth factor-beta1 (TGF-beta1) is a multi-functional cytokine that presents as a mediator of the heparin's pleiotropic action. In this cross-over study, we compared the effects of enoxaparin and unfractionated heparin (UFH) used as anticoagulants during haemodialysis (HD) on plasma TGF-beta1 levels and some platelet activation markers: platelet-derived growth factor-AB (PDGF-AB), beta-thromboglobulin (beta-TG) and platelet factor-4 (PF-4).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research